Serotonin syndrome and cannabis: A case report (Letter)
File version
Version of Record (VoR)
Author(s)
Wu, Chaston
Burke, Sophie
Parker, Stephen
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
Abstract
Dear Editor, The increasing availability of cannabis administration devices (e.g. ‘vapes’ and ‘dab pens’) and medicinal cannabis with high ∆9-tetrahydrocannabinol (THC) concentrations may introduce novel complications of cannabis use. Cannabinoids predominantly act through the endogenous cannabinoid system, but animal studies suggest these compounds can also stimulate serotonin receptors.
Journal Title
Australasian Psychiatry
Conference Title
Book Title
Edition
Volume
Issue
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
© The Royal Australian and New Zealand College of Psychiatrists 2023. This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Item Access Status
Note
This publication has been entered in Griffith Research Online as an advanced online version.
Access the data
Related item(s)
Subject
Biomedical and clinical sciences
Health sciences
Psychology
Science & Technology
Life Sciences & Biomedicine
Psychiatry
Persistent link to this record
Citation
Nadeem, Z; Wu, C; Burke, S; Parker, S, Serotonin syndrome and cannabis: A case report, Australasian Psychiatry, 2023